Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer | NeoGenomics Laboratories

Publication date

Thu, 04/02/2020 - 12:00

Category

Year

Subtitle

JCO Precision Oncology

External link

https://ascopubs.org/doi/full/10.1200/PO.19.00281?journalCode=po

Division